Spark Therapeutics, Inc.

PA · United States · Reporting entity ID 100000226812

Total reported 2019–2025

$29.4M

#245 of 2,960 reporting companies — 0% of all reported industry payments

$15.5M in general payments across 2,859 records, plus $13.9M in research funding across 1,158 records.

How it breaks down

General payments $15,453,874

Research funding $13,948,762

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.